Tonix Pharmaceuticals Holding Corp ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $672.00 on 05/17/24, while the lowest value for the same period was recorded at $6.76 on 03/04/25.
52-week price history of TNXP Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Tonix Pharmaceuticals Holding Corp’s current trading price is -97.35% away from its 52-week high, while its distance from the 52-week low is 163.31%. The stock’s price range during this period has spanned from $6.76 to $672.00. In the Healthcare sector, the Tonix Pharmaceuticals Holding Corp’s shares surpassed a trading volume of approximately 1.24 million for the day, which was noticeably lower compared to the average daily volume of 9.1.66 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Tonix Pharmaceuticals Holding Corp (TNXP) has experienced a quarterly decline of -42.58% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 122.43M and boasts a workforce of 81 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 21.91, with a change in price of +3.70. Similarly, Tonix Pharmaceuticals Holding Corp recorded 1,623,036 in trading volume during the last 100 days, posting a change of +26.24%.
Examining TNXP’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for TNXP stands at 0.06. Similarly, the long-term debt-to-equity ratio is also 0.04.
TNXP Stock Stochastic Average
Today’s raw stochastic average for Tonix Pharmaceuticals Holding Corp over the last 50 days is 21.42%.This indicates a increase from the raw stochastic average of the past 20 days, which was 21.39%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 18.16% and 20.88%, respectively.
TNXP Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The index has shown a price loss of -46.03% this year. Over the last six months, there has been a weaker performance of 41.27%. The price of TNXP fallen by 36.71% during the last 30 days period. For the last 5-days stocks have slided -0.42%.
